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Abstract
Introduction: To evaluate the degree of atherosclerosis in children and adolescents with type 1 diabetes and its correlation with risk fac-
tors, traditional and other, such as anti-oxidative capacity of circulating blood and level of lipid peroxidation. 
Material and methods: Forty children and adolescents with type 1 diabetes with mean age 13.7 years were compared with 20 age- and 
sex-matched healthy control subjects. Association of carotid artery intima-media thickness (cIMT) with different risk factors measured in 
children with type 1 diabetes was evaluated.
Results: Mean carotid IMT was higher in subjects with diabetes (p < 0.01) and was strongly associated with total cholesterol with an odds 
ratio of 4.08 (p = 0.016), LDL-cholesterol with an odds ratio of 2.78 (p = 0.037), length of disease with an odds ratio of 1.87 (p = 0.007) 
and positive family history (first- and second-degree relatives) of diabetes and early CVD (heart attack and/or stroke before the age of 
60 years) with an odds ratio of 6.8 (p = 0.007). 
Conclusions: We found significantly increased cIMT in the diabetic patients compared to the healthy control subjects. Risk factors for 
the development of atherosclerosis included higher total and LDL-cholesterol, higher systolic blood pressure, positive family history of 
diabetes and early CVD and longer diabetes duration. In spite of the documented increased oxidative stress, we failed to establish a cor-
relation between the oxidative stress parameters and cIMT values. (Endokrynol Pol 2012; 63 (6): 414–419)
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Streszczenie
Wstęp: Ocena stopnia zaawansowania miażdżycy u dzieci i młodzieży z cukrzycą typu 1 oraz jego korelacja z czynnikami ryzyka, trady-
cyjnymi i innymi, na przykład potencjałem antyoksydacyjnym krwi krążącej i poziomem peroksydacji lipidów.
Materiał i metody: Porównano 40 dzieci i nastolatków z cukrzycą typu 1, średnia wieku 13,7 roku, z 20 zdrowymi osobnikami stanowią-
cymi grupę kontrolną odpowiednio dobranymi pod względem wieku i płci. Oceniano związek pomiędzy grubością kompleksu błony 
wewnętrznej i środkowej tętnic szyjnych (cIMT) a różnymi czynnikami ryzyka ocenianymi ilościowo u dzieci z cukrzycą typu 1.
Wyniki: Średnia wartość cIMT była większa u pacjentów z cukrzycą (p < 0,01) i wykazywała silny związek ze stężeniem cholestero-
lu całkowitego [iloraz szans (OR) 4,08; p = 0,016], cholesterolem frakcji LDL (OR 2,77; p = 0,037), czasem trwania choroby (OR 1,87; 
p = 0,007) i dodatnim wywiadem rodzinnym (krewni pierwszego i drugiego stopnia) w kierunku cukrzycy i wczesnego występowania 
chorób układu krążenia (zawału serca i/lub udaru mózgu przed 60. rokiem życia) (OR 6,8; p = 0,007). 
Wnioski: Stwierdzono znamiennie podwyższoną wartość cIMT u pacjentów z cukrzycą w porównaniu ze zdrowymi osobnikami z grupy 
kontrolnej. Czynniki ryzyka rozwoju miażdżycy obejmowały podwyższone stężenie cholesterolu całkowitego i cholesterolu frakcji LDL, 
podwyższone skurczowe ciśnienie tętnicze, dodatni wywiad rodzinny w kierunku cukrzycy i wczesnego występowania chorób układu 
krążenia oraz dłuższy czas trwania cukrzycy. Pomimo udokumentowanego wzmożenia stresu oksydacyjnego nie udało się ustalić korelacji 
pomiędzy parametrami stresu oksydacyjnego a wartościami cIMT. (Endokrynol Pol 2012; 63 (6): 414–419)
Słowa kluczowe: determinanty, miażdżyca, dzieci, cukrzyca typu 1
Introduction
Diabetes mellitus type 1 remains the major endocrine 
health problem in childhood in our country, unfor-
tunately, with growing incidence [1, 2]. Despite the 
progress made over the past decades in the treatment 
of children and adolescents with diabetes type 1, these 
patients still have a several fold greater risk for devel-
opment of coronary, cerebrovascular and peripheral 
arterial diseases during their young adulthood [3–5]. 
In the background of these conditions lies a more 
aggressive process of atherosclerosis to which these 
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patients are prone. Hyperglycaemia and increased 
oxidative stress play pivotal roles in the early stages 
of atherogenesis in diabetes, including impairment of 
endothelial function and the formation of fatty streaks 
and plaques.
Although our understanding of who is at risk for 
macrovascular disease in type 1 diabetes is still far from 
complete, patients with poor glycoregulation [6], longer 
duration of diabetes [7], early onset of the disease [8] 
accompanied by standard cardiovascular risk factors, 
including a family history of cardiovascular disease and 
type 2 diabetes, should be considered at increased risk. 
Furthermore, oxidative stress as well as defects in 
antioxidant defence systems are recognised as causative 
factors for the development of major diabetic complica-
tions [9].
Common carotid artery intima-media thickness 
(cIMT) measured by high resolution B-mode ultra-
sonography is a non-invasive marker of subclinical ath-
erosclerosis that has been used widely in these patients 
to assess vascular health [10]. However, information 
on the association of cIMT with different risk factors 
measured in children with type 1 diabetes is still limited. 
Therefore, we evaluated the determinants of athero-
sclerosis, traditional and other, such as anti-oxidative 
capacity of circulating blood and level of lipid peroxi-
dation and their connection with cIMT in children and 
adolescents with type 1 diabetes. 
Material and methods
Patients
Forty children with diabetes mellitus type 1 and 20 age- 
and sex-matched control subjects were enrolled in the 
study. The diagnosis of diabetes mellitus was based on 
the current criteria of the American Diabetes Association. 
All patients were recruited consecutively during their 
regular three-month visits as outpatients at a tertiary 
health care centre (Children’s Hospital Niš, Division 
of Endocrinology). Medical records were available for 
all patients (data on HbA1c and insulin dosage as well 
as on diabetic complications) for the entire follow-up 
period. Subjects were excluded if they had evidence or 
history of clinically relevant systemic disease. All patients 
were free of any microvascular complication of diabetes 
(retinopathy, nephropathy or neuropathy). The mean 
HbA1c was calculated as the arithmetic mean value of 
the last three HbA1c levels measured during the regular 
follow-up visits at the outpatient department. Family 
history (first- and second-degree relatives) of diabetes 
type 2 and early CVD (heart attack and/or stroke before 
the age of 60 years) was determined by questionnaire. 
Written informed consent was obtained for all partici-
pants from their legal guardians and the study protocol 
was approved by the local ethics committee. The mean 
age of patients was 13.9 ± 2.8 years. The control group 
comprised 20 healthy subjects: 13 girls and seven boys, 
average age 13.1 years.
Methods 
Blood pressure measurements
Blood pressure was obtained using a conventional os-
cillatory measurement system positioned at the right 
upper arm. The size of the cuff was chosen depending 
on the patient’s arm circumference, with the cuff blad-
der covering at least 40% up to a maximum of 100% of 
the arm circumference. 
Laboratory procedures
Blood samples were taken during the patients’ follow-
up visit. Fasting HbA1c, triglycerides, total cholesterol, 
high density (HDL) and low density cholesterol were 
measured by standard laboratory methods. 
Oxidative stress parameters
Thiobarbituric acid reacting substances (TBARS) con-
tent, a measure of lipid peroxidation, was assayed in 
plasma and red blood cells according to the methods 
of Andreeva [11] and Jejin [12].
The catalase activity was determined by the spec-
trophotometric method, based on the ability of hydro-
gen peroxide to form a stable stained complex with 
molybdenum salts [13]. An improved method for the 
determination of total serum SH groups was based 
on the formation of colour product, monitored at 
412 nm after addition of Ellman reagent (5, 5’-dithiobis-
2-nitrobenzoic acid) [14].
Ultrasonography
All ultrasound studies were done according to a stand-
ardised scanning protocol for the right and left common 
carotid arteries [15]. High resolution carotid ultrasound 
studies were performed (Acuson, Siemens) with a 12 MHz 
transducer. Before beginning the ultrasound imaging, 
subjects lay quietly on a bed. The study protocol involved 
scanning of the far wall of the right and left common ca-
rotid arteries in the distal 1.0–1.5 cm. In each examination, 
different scanning angles (anterior, latero-posterior) were 
adopted to record the greatest intima-media thickness. 
Three determinations of the right and the left carotid 
artery were performed and these three determinations 
were averaged. Furthermore, the right and the left carotid 
artery measurements were averaged and used for analysis 
(mean cIMT). The examiners were blinded to the subject. 
Ten patients presented twice for the determination of in-
traobserver variability within seven weeks and the cIMT 
was measured without knowledge of the previous values. 
The intraobserver variability was ≤ 5%. 
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Table I. Anthropometric, clinical, biochemical and ultrasonic characteristics
Tabela I. Charakterystyka antropometryczna, kliniczna, biochemiczna i ultrasonograficzna
Study group (n = 40) Control group (n = 20) p
Age 13.86 ± 2.73 13.18 ± 2.58 0.358
Sex (male/female) 27/13 11/9 0.507
Weight [kg] 47.33 ± 13.66 42.20 ± 10.06 0.142
Height [cm] 156.42 ± 14.93 155.88 ± 14.39 0.894
BMI 18.92 ± 3.28 17.15 ± 2.36 0.036*
Smoking (%) 7,5% 5% 0,644
Total cholesterol [mg/dL] 4.53 ± 0.80 4.41 ± 0.63 0.561
LDL-cholesterol [mg/dL] 3.16 ± 0.86 3.13 ± 0.64 0.891
HDL-cholesterol [mg/dL] 0.96 ± 0.36 0.95 ± 0.23 0.910
Triglycerides [mg/dL] 0.82 ± 0.66 0.79 ± 0.72 0.872
HbA1c 9.23 ± 1.63 5.1 ± 0.6  < 0.001***
MDAs [μmol/L]1 29.12 ± 16.16 7.6 ± 1.56  < 0.001***
MDAer [μmol/L)2 13.03 ± 3.61 4.17 ± 0.68  < 0.001***
SH [μmol/L]3 347.52 ± 223.39 393.65 ± 114.94 0.390
Catalase 136.14 ± 36.46 129.97 ± 41.29 0.557
Mean combined cIMT [mm]4 0.45 ± 0.06 0.40 ± 0.06  < 0.003**
*p < 0.05, **p < 0.01, ***p < 0.001; 1MDAS — malondialdehyde in sera; 2MDAer — malondialdehyde in red blood cells; 3SH — sulphhydryl group; 
4cIMT — carotid artery intima-media thickness
Statistical analysis
Statistical analyses were performed using SPSS 16.0. 
Values are expressed as mean ± SD. Comparisons 
between subjects with diabetes mellitus type 1 and 
controls were made using paired Student’s t-tests 
and chi-square analysis for continuous and categori-
cal variables, respectively. To examine risk factors, 
univariate logistic regression was used. A p value of 
< 0.05 was considered statistically significant.
Results
The clinical characteristics of the participants in 
the present study are shown in Table I. The groups 
(diabetic patients and healthy control subjects) were 
similar regarding sex and age. However, a significant 
difference was observed between the groups regard-
ing BMI with higher values among the diabetic pa-
tients (p < 0.036). 
Considering lipid profile, there was no significant differ-
ence between patients and the control group. In the diabetic 
group, mean HgbA1c was higher 9.23 ± 1.63 % (p < 0.01).
Oxidative stress was assesed by measuring the level 
of malondialdehyde (MDA), a marker of lipid peroxida-
tion in serum and erythrocites. We found a significantly 
increased level of lipid peroxidation in diabetic patients 
in serum 29.12 ± 16.16 μmol/L v. 7.6 ± 1.56 μmol/L 
(p < 0.001), and in erythrocites 13.03 ± 3.61 μmol/L 
v. 4.17 ± 0.68 (p < 0.001). In spite of high lipid peroxida-
tion in the diabetic group, the activity of antioxidative 
enzymes catalase and tiol groups were modest, with no 
significant difference within groups. cIMT was signifi-
cantly higher in the diabetic than in the control group 
0.45 ± 0.06 v. 0.40 ± 0.06 (p < 0.003). 
Furthermore, we divided diabetic patients into 
two groups: the first group with cIMT below the 95th 
percentile and the second group with cIMT above 
the 95th percentile, according to proposed norma-
tive values for European children [14] (Table II). We 
compared their clinical and metabolic caracteristics. 
The group with cIMT above the 95th percentile was 
significantly older 14.77 ± 2.38 years v. 12.61 ± 2.75 
years (p < 0.009), taller 162.00 ± 11.16 cm v. 148.75 ± 
± 16.33 cm (p < 0.002), had greater body weight 53.20 
± 11.22 kg v. 39.25 ± 11.44 kg (p < 0.006), higher BMI 
(p < 0.003) and had longer disease duration 6.94 ± 
± 4.70 years v. 3.22 ± 2.68 (p < 0.001) years compared 
to the other group.
No significant difference was found in systolic and 
diastolic blood pressure, age at onset of disease, insulin 
dose, and level of HgbA1c between these two groups. 
Fourteen patients with cIMT above the 95th percentile, 
and only two patients from the other group, were on 
intensive insulin treatment. 
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Patients with increased cIMT had significantly higher 
levels of total (p < 0.007) and LDL cholesterol (p < 0.025).
Considering oxidative stress, we found a nonsignifi-
cantly higher level of lipid peroxidation, and nonsignifi-
cantly lower activity of catalase and thiol groups in the 
group with cIMT above the 95th percentile.
Univariate logistic regression showed that the 
increased cIMT in 40 patients was significantly as-
sociated with total cholesterol with an odds ratio of 
4.08 (p = 0.016), LDL-cholesterol with an odds ratio 
of 2.78 (p = 0.037), length of disease with an odds 
ratio of 1.87 (p = 0.007) and positive family history 
(first- and second-degree relatives) of diabetes type 
2 and early CVD (heart attack and/or stroke before 
the age of 60 years) with an odds ratio of 6.8 (p = 
= 0.007) (Table III).
Table II. Clinical characteristics of patients with cIMT < P95th and cIMT > P95th
Tabela II. Charakterystyka kliniczna pacjentów z cIMT poniżej 95. percentyla i cIMT powyżej 95. percentyla
cIMT < P95th  
(n = 17)
cIMT > P95th  
(n = 23)
p
Age (years) 12.61 ± 2.75 14.77 ± 2.38 0.009*
Sex (male/female) 6/11 7/16 0.986
Weight [kg] 39.25 ± 11.44 53.20 ± 11.22 0.006*
Height [cm] 148.75 ± 16.33 162.00 ± 11.16 0.002*
BMI 17.32 ± 2.18 20.09 ± 3.47 0.003*
Diastolic blood pressure [mm Hg] 66.43 ± 6.63 66.00 ± 7.37 0.079
Systolic blood pressure [mm Hg] 107.50 ± 7.78 111.33 ± 5.16 0.729
Insulin dose I/kg 0.74 ± 0.28 0.96 ± 0.44 0.079
Conventional/intensive insulin therapy (n) 15/2 9/14 0.004*
Age at onset (years) 8.82 ± 3.96 7.94 ± 3.38 0.448
Diabetes duration (years) 3.22 ± 2.68 6.94 ± 4.70 0.001**
Total cholesterol [mg/dL] 4.15 ± 0.58 4.82 ± 0.83 0.007*
LDL-cholesterol [mg/dL] 2.86 ± 0.68 3.48 ± 0.93 0.025*
HDL-cholesterol [mg/dL] 0.95 ± 0.28 0.97 ± 0.40 0.857
Triglycerides [mg/dL] 0.76 ± 0.76 0.84 ± 0.57 0.704
Hba1c 8.99 ± 1.19 9.42 ± 1.90 0.315
MDAs [μmol/L] 22.62 ± 15.72 35.19 ± 14.53 0.246
MDAer [μmol/L] 12.68 ± 2.65 13.36 ± 4.39 0.544
SH [μmol/L] 392.86 ± 229.21 305.20 ± 216.91 0.124
Catalase 138.58 ± 31.09 133.86 ± 41.84 0.737
*p < 0.05, **p < 0.01
Table III. Risk factors for intima-media thickness (univariate logistic regression)
Tabela III. Czynniki ryzyka dla zwiększonej grubości kompleksu błony wewnętrznej i środkowej (jednoczynnikowa regresja 
logistyczna)
Independent variable OR 95% CI P
Total cholesterol 4.08 1.31–12.74 0.016*
LDL-cholesterol [mg/dL] 2.78 1.06–7.28 0.037*
Systolic blood pressure [mm Hg] 1.11 0.99–1.24 0.081*
Duration of disease (years) 1.87 1.19–2.95 0.007*
Positive family history of diabetes type 2 and early CVD 6.8 1.68–27.52 0.007*
OR — odds ratio; 95% CI — 95% confidence interval
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Discussion
Several researchers have conducted studies on cIMT 
in paediatric patients with diabetes mellitus type 1 
[16–20]. Like most cited studies on the subject [18, 21], 
the present study revealed a significantly increased 
intima-media thickness in a group of children and 
adolescents with diabetes mellitus type 1.
The diabetic patients in this study had higher BMI 
than the control subjects, as shown in previous studies. 
This is often explained by overinsulinisation during 
intensive insulin treatment, frequent hypoglycaemic 
episodes treated by additional food intake, and nutri-
tional liberation leading to increased energy intake [22].
A direct association between age, height, weight, 
BMI and cIMT was found in this study. Although cIMT 
increases with age in adults, this relationship has not 
been clearly demonstrated in children and adolescents 
[19, 23]. It was shown in previous studies that cIMT 
increases slightly with age but is more closely related 
to height than to age [16].
According to current ISPAD guidelines of quality 
of glycaemic control, our patients had poor metabolic 
control with mean HgbA1c of 9.23 ± 1.63%. Consistent 
with previous studies, we were not able to establish 
a direct association between the HbA1c and the values 
of IMT. Data from the literature indicates, however, 
that in contrast to the functional impairment of the 
endothelium, structural changes do not correlate to 
a single parameter such as the HbA1c at a young age [8]. 
In the diabetic group as a whole, in spite of poor 
glycaemic control, the mean values of total, HDL and 
LDL cholesterol, triglycerides, were not significantly 
higher than in the control subjects. But in the group 
with elevated cIMT, total and LDL cholesterol were 
significantly higher than in the group with smaller 
cIMT. Our results are comparable with some previous 
studies [19, 24].
Lipids, the substrate under greatest attack by free 
radicals, have been extensively studied, and in diabetic 
patients are of special interest because their hyperlipi-
daemia is considered to be a significant risk factor for 
the development of vascular complications [25, 26]. 
Peroxidation of fatty acids produces aldehydes such as 
thiobarbituric acid reacting substances (TBARS). The 
most commonly measured TBARS is malondialdehyde 
[27]. We documented significantly increased lipid 
peroxidation in the sera and red blood cells of type 1 
diabetes patients. 
Catalase is one of the most potent and widely di-
stributed antioxidant enzymes. Catalase has a role in 
eliminating hydrogen peroxide before it has a chance 
to react with ferro ions and form potent free oxygen 
radicals, such as hydroxil radicals. Thiol groups such 
as glutathion, cystein and homocystein (all contain SH 
groups and are referred to as sulphhydryl groups) re-
present another important antioxidant defence system. 
Glutathion is oxidated by lipid peroxides under the 
influence of glutathion peroxidase yielding glutathion 
disulphide, indicating that glutathion may serve a 
purpose in detoxifying lipid peroxides. Relatively low 
activity of catalase and thiol groups in the condition of 
significantly increased lipid peroxidation in our study 
could be a sign of impairment of antioxidative activity 
in diabetic patients. We have documented that oxida-
tive stress takes place early in type 1 diabetes through 
increased lipid peroxidation, but we failed to establish 
a direct correletion between oxidative stress and cIMT. 
In our study, no significant correlation between cIMT 
and age at onset, insulin dosage or intensive insulin 
treatment was found.
Conclusions
In conclusion, we were able to show significantly in-
creased cIMT in 23 patients out of a total of 40 children 
and adolescents with type 1 diabetes mellitus. Risk 
factors for the development of atherosclerosis included 
higher total and LDL-cholesterol, higher systolic blood 
pressure, positive family history of diabetes and early 
CVD and longer diabetes duration. In spite of the high 
level of lipid peroxidation and documented poor gly-
caemic control, we were not able to establish a direct 
correlation between the HbA1c and lipid peroxidation 
with the values of cIMT. Measuring cIMT is useful tool 
in determining early atherosclerosis that can give us 
information as to who is at increased risk of developing 
macrovascular complications on an individual basis. 
Lowering cardiovascular risk in this high-risk group of 
children must be warranted [28].
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